Ambrx Biopharma Inc. Finite-Lived Intangible Assets, Net
Ambrx Biopharma Inc. had Finite-Lived Intangible Assets, Net of $4.31 million as of 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2023-03-30
- 2022-12-31: Finite-Lived Intangible Assets, Net $4.31M.
- 2021-12-31: Finite-Lived Intangible Assets, Net $15.02M.
| Period end | Finite-Lived Intangible Assets, Net |
|---|---|
| 2022-12-31 | $4.31M 10-K · filed 2023-03-30 |
| 2021-12-31 | $15.02M 20-F · filed 2022-04-26 |